BIO Submits Comments Re: Medicare Shared Savings Program: Accountable Care Organizations Proposed Rule
<div>
Marilyn Tavenner</div>
<div>
Administrator</div>
<div>
Centers for Medicare & Medicaid Services</div>
<div>
Department of Health and Human Services</div>
<div>
Room 445-G</div>
<div>
Hubert H. Humphrey Building</div>
<div>
200 Independence Avenue, S.W.</div>
<div>
Washington, D.C. 20201</div>
<div>
</div>
<div>
Re: Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations</div>
<div>
</div>
<div>
Dear Administrator Tavenner:</div>
<div>
</div>
<div>
The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS) proposed rule regarding the Medicare Shared Savings Program (MSSP) and Accountable Care Organizations (ACOs) (the “Proposed Rule”).1 BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of health care, agricultural, industrial, and environmental biotechnology products.</div>